Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-01-18 06:15 am Sale | 2022-01-14 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 0 0.000% | -475,856 (Position Closed) | Filing History |
2022-01-18 06:12 am Purchase | 2022-01-13 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 475,856 5.980% | 193,267 (+68.39%) | Filing History |
2021-11-24 09:13 am Sale | 2021-11-24 | 13G | Minerva Neurosciences, Inc. NERV | Assenagon Asset Management S.A. | 173,186 3.240% | -586,978 (-77.22%) | Filing History |
2021-11-24 09:11 am Purchase | 2021-11-23 | 13G | Minerva Neurosciences, Inc. NERV | Assenagon Asset Management S.A. | 760,164 14.230% | 760,164 (New Position) | Filing History |
2020-08-06 11:13 am Purchase | 2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 282,589 6.390% | 222,819 (+372.79%) | Filing History |
2020-08-06 11:13 am Purchase | 2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 59,771 1.070% | 59,771 (New Position) | Filing History |
2020-08-04 11:27 am Sale | 2020-08-04 | 13G | Impinj, Inc. PI | Assenagon Asset Management S.A. | 413,869 1.810% | -762,338 (-64.81%) | Filing History |
2020-08-04 08:48 am Purchase | 2020-08-03 | 13G | Impinj, Inc. PI | Assenagon Asset Management S.A. | 1,176,207 5.150% | 527,411 (+81.29%) | Filing History |
2020-06-24 12:25 pm Sale | 2020-06-23 | 13G | LendingClub Corporation LC | Assenagon Asset Management S.A. | 2,096,071 3.000% | -1,651,200 (-44.06%) | Filing History |
2020-06-24 12:17 pm Purchase | 2020-06-19 | 13G | LendingClub Corporation LC | Assenagon Asset Management S.A. | 3,747,271 5.360% | 3,747,271 (New Position) | Filing History |
2020-06-19 10:20 am Sale | 2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 59,771 1.070% | -222,819 (-78.85%) | Filing History |
2020-06-19 10:18 am Purchase | 2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 282,589 6.390% | 282,589 (New Position) | Filing History |
2020-06-17 11:54 am Unchanged | 2020-06-15 | 13G | Affimed N.V. AFMD | Assenagon Asset Management S.A. | 78 1.020% | 0 (Unchanged) | Filing History |
2020-06-16 10:59 am Sale | 2020-06-15 | 13G | Affimed N.V. AFMD | Assenagon Asset Management S.A. | 78 1.020% | -497,934 (-99.98%) | Filing History |
2020-06-16 10:55 am Purchase | 2020-06-12 | 13G | Affimed N.V. AFMD | Assenagon Asset Management S.A. | 498,012 6.530% | 498,012 (New Position) | Filing History |
2020-04-17 11:05 am Sale | 2020-04-16 | 13G | Magnachip Semiconductor Corporation MX | Assenagon Asset Management S.A. | 765,661 2.200% | -1,627,391 (-68.00%) | Filing History |
2020-04-17 09:16 am Purchase | 2020-04-15 | 13G | Magnachip Semiconductor Corporation MX | Assenagon Asset Management S.A. | 2,393,052 6.880% | 2,393,052 (New Position) | Filing History |